Raptor Pharma (RPTP) Misses Q4 EPS by 15c

Raptor Pharma (NASDAQ: RPTP) reported Q4 EPS of ($0.29), $0.15 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $20.12 million.

For earnings history and earnings-related data on Raptor Pharma (RPTP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings